US Fertility enters a strategic partnership with L Catterton and Amulet Capital Partners to enhance its capacity to provide advanced reproductive technologies.

Target Information

US Fertility represents the leading physician-owned fertility services platform across the United States. In 2025, the company announced a strategic partnership with prominent investors L Catterton and Amulet Capital Partners. This collaboration highlights US Fertility's commitment to enhancing its capabilities in providing advanced reproductive technologies, thereby addressing the growing demand within the sector.

The revised ownership structure allows L Catterton, a major player in global consumer-focused private equity, and Amulet Capital Partners, a dedicated healthcare-focused investment firm, to act as co-lead investors. US Fertility's physician partners maintain significant ownership, ensuring a blend of investment and clinical expertise within the platform.

Industry Overview

The fertility care industry in the United States is witnessing substantial growth, driven by an increasing demand for services such as in-vitro fertilization (IVF), intrauterine insemination (IUI), and genetic testing. The market has become attr